Kestra Advisory Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Buy |
2,227
+314
| +16% | +$39.4K | ﹤0.01% | 2398 |
|
|
2025
Q1 | $262K | Sell |
1,913
-236
| -11% | -$32.3K | ﹤0.01% | 2268 |
|
|
2024
Q4 | $329K | Sell |
2,149
-107
| -5% | -$16.4K | ﹤0.01% | 2148 |
|
|
2024
Q3 | $437K | Sell |
2,256
-662
| -23% | -$128K | ﹤0.01% | 1848 |
|
|
2024
Q2 | $676K | Buy |
2,918
+28
| +1% | +$6.49K | ﹤0.01% | 1579 |
|
|
2024
Q1 | $623K | Buy |
2,890
+119
| +4% | +$25.7K | ﹤0.01% | 1520 |
|
|
2023
Q4 | $717K | Buy |
2,771
+113
| +4% | +$29.2K | 0.01% | 1301 |
|
|
2023
Q3 | $683K | Sell |
2,658
-371
| -12% | -$95.4K | 0.01% | 1199 |
|
|
2023
Q2 | $863K | Buy |
3,029
+750
| +33% | +$214K | 0.01% | 1049 |
|
|
2023
Q1 | $634K | Sell |
2,279
-6,163
| -73% | -$1.71M | 0.01% | 1161 |
|
|
2022
Q4 | $2.34M | Sell |
8,442
-109
| -1% | -$30.2K | 0.02% | 686 |
|
|
2022
Q3 | $2.28M | Sell |
8,551
-491
| -5% | -$131K | 0.02% | 621 |
|
|
2022
Q2 | $1.84M | Sell |
9,042
-410
| -4% | -$83.6K | 0.02% | 703 |
|
|
2022
Q1 | $1.99M | Buy |
9,452
+2,190
| +30% | +$461K | 0.02% | 677 |
|
|
2021
Q4 | $1.74M | Sell |
7,262
-4,888
| -40% | -$1.17M | 0.02% | 745 |
|
|
2021
Q3 | $3.44M | Sell |
12,150
-2,346
| -16% | -$664K | 0.03% | 516 |
|
|
2021
Q2 | $5.02M | Buy |
14,496
+525
| +4% | +$182K | 0.06% | 361 |
|
|
2021
Q1 | $3.91M | Buy |
13,971
+9,462
| +210% | +$2.65M | 0.05% | 387 |
|
|
2020
Q4 | $1.1M | Buy |
4,509
+4,483
| +17,242% | +$1.09M | 0.01% | 833 |
|
|
2020
Q3 | $633K | Buy |
+26
| New | +$633K | 0.01% | 788 |
|